Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial

Medical Xpress

Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to substantial weight loss in people with Type 2 diabetes.

The study included adults with Type 2 diabetes who were not taking diabetes medicines and whose blood sugar was not adequately controlled with diet and exercise alone. ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

A robot that reads bacteria by touch, without staining or chemical labels

How studying oral inflammatory diseases can help researchers understand other human diseases

World's largest whale graveyard discovered by Chinese sub

Medical Xpress의 다른 기사

The same sounds are mapped similarly in the human and mouse brain, study finds

Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients

Bacterial responses to plasma may forecast mild vs severe COVID-19